News Sandoz's Enbrel biosimilar approved in US FDA approves first near-copy of inflammatory diseases drug.
News Amgen's Prolia succeeds in glucocorticoid-induced osteoporos... Possible new use for well-established drug.
News NICE recommends Amgen’s melanoma treatment after price cut Drug only approved when systemic immunotherapies are not suitable
News Biogen, Denali pull Parkinson's drug after failed trial Biogen has stopped development of Denali-partnered Parkinson's disease candidate BIIB122, after it failed to move the needle in a phase 2b trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
